Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Depreciation & Amortization (CF): 2020-2025

Historic Depreciation & Amortization (CF) for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Sep 2025 value amounting to $584,000.

  • Insight Molecular Diagnostics' Depreciation & Amortization (CF) rose 83.65% to $584,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 77.49%. This contributed to the annual value of $1.5 million for FY2024, which is 6.25% down from last year.
  • As of Q3 2025, Insight Molecular Diagnostics' Depreciation & Amortization (CF) stood at $584,000, which was up 4.47% from $559,000 recorded in Q2 2025.
  • Insight Molecular Diagnostics' Depreciation & Amortization (CF)'s 5-year high stood at $584,000 during Q3 2025, with a 5-year trough of $121,000 in Q1 2021.
  • For the 3-year period, Insight Molecular Diagnostics' Depreciation & Amortization (CF) averaged around $428,727, with its median value being $435,000 (2023).
  • Per our database at Business Quant, Insight Molecular Diagnostics' Depreciation & Amortization (CF) skyrocketed by 269.57% in 2021 and then crashed by 30.44% in 2024.
  • Insight Molecular Diagnostics' Depreciation & Amortization (CF) (Quarterly) stood at $206,000 in 2021, then spiked by 94.17% to $400,000 in 2022, then decreased by 25.00% to $300,000 in 2023, then skyrocketed by 88.33% to $565,000 in 2024, then soared by 83.65% to $584,000 in 2025.
  • Its Depreciation & Amortization (CF) was $584,000 in Q3 2025, compared to $559,000 in Q2 2025 and $484,000 in Q1 2025.